|
|
Flinders Academic Commons >
Research Publications >
07 - Biomedical and Clinical Research >
1112 - Oncology and Carcinogenesis >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2328/11137
|
| Title: | Importance of minimal residual disease testing
during the second year of therapy for children with acute lymphoblastic
leukemia |
| Authors: | Waters, K
Webster, Boyd
Zhu, L
Sykes, Pamela Joy
Morley, Alexander Alan
Brisco, Michael
Chengyuan, X
Dalla Pozza, L
Ferrara, D
Haber, M
Kwan, E
Marshall, G M
Norris, M D |
| Issue Date: | 2003 |
| Citation: | Marshall, G.M., Haber, M., Kwan, E., Zhu,
L., Ferrara, D., Chengyuan, X., Brisco, M., Sykes, P.J., Morley, A.A., Webster, et al.,
2003. Importance of minimal residual disease testing during the second year of therapy
for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21(4),
704-709. |
| URI: | http://hdl.handle.net/2328/11137 |
| ISSN: | 0732-183X |
| Appears in Collections: | 1112 - Oncology and Carcinogenesis
|
Files in This Item:
There are no files associated with this item.
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
